Objective: Using cell-free fetal DNA (cffDNA) and amplicon-based next generation sequencing (NGS) to develop a safe and accurate non-invasive prenatal test to detect fetal inheritance of paternal mutations for β-thalassaemia mutations (including HbE mutation).